This document discusses technology innovation in NHS Scotland. It explores different types of technologies including bio, information, communication, device, and pharmaceutical technologies. It defines innovation and shows a spectrum from sustaining to disruptive innovation. It notes that healthcare has been a slow adopter of technology. Studies show telehealth can reduce A&E visits, admissions, and mortality if used correctly. Issues around procurement, the healthcare market, and enabling staff and patients to change are discussed.

1. Session 1.1 Technology Innovation in NHSScotland: The Big Debate
Explore and Understand

3. •
•
•

5. Information
Bio- technologies technologies
Communications
technologies
Device
Technologies Pharmaceutical
technologies
‘assistive’ Diagnostic Other
technologies technologies Technologies !

6. A definition of ‘innovation’
7

7. Spectrum of Innovation
Sustaining Disruptive
(Comfort Zone) (Risk Taking)
Doing what we do Creating what
today, better we will do
tomorrow
8

8. Healthcare is a late, slow
adopter of technology.
Sir Derek Wanless
2004

9. •
•
•

16. Omachonu,V.K & Einspruch, N.G 2010

19. Innovation, Productivity
and Quality
Richard Carey
Chief Executive
NHS Grampian

20. GP
Pharmacy Specialist
HOSPITAL
Patient Nurse

22. PREVENTION

27. Planned and
Unscheduled Care

28. VARIANNCE
Are there significant variations in hospital expenditure by
GP practice?
1,200
1,000
800
£ per weighted head
600
400
200
0
Practices
Emergency Elective

29. Early headline findings NHS England
Whole System Demonstrator
The early indications show that if used
correctly telehealth can deliver a 15%
reduction in A&E visits, a 20% reduction
in emergency admissions, a 14%
reduction in elective admissions, a 14%
reduction in bed days. More strikingly
they also demonstrate a 45% reduction
in mortality rates.

31. 12%reduction in outpatient attendences
No delays

33. Clinical Guidance Intranet

34. 2
years!

35. Technology
changes every 6
months?

37. X PRIZE

38. Emerging Technology
and Adoption

43. PROCUREMENT
•ROLE OF HEALTH INNOVATION
PARTNERSHIPS AND LIFE SCIENCES?
•HOW DO SME’S FIT IN?
•OVERCOMMING THE COST BARRIER-SHARED
RISK/BENEFIT
•DIGITAL BY DEFAULT(90% interactions are face
to face)
•HOW WILL HEAT SUPPORT DIFUSION?
•ROLE OF NHS 24?
•HOW DO WE ENABLE STAFF AND PATIENTS
TO CHANGE?

44. HEALTH CARE
MARKET
•$3TRILLION WORLD WIDE MARKET
•NHS£109B
•BIGGEST DETERMINANT TO WEALTH IS
HEALTH
•MARKET SLOW TO ADOPT NEW
PRODUCTS/PROCESSES

46. •
•